How Can HIV-Type-1-Env Immunogenicity Be Improved to Facilitate Antibody-Based Vaccine Development?-Reference-Cited by-同舟云学术

How Can HIV-Type-1-Env Immunogenicity Be Improved to Facilitate Antibody-Based Vaccine Development?

Published:2012-01 Issue:1 Volume:28 Page:1-15
ISSN:0889-2229
Container-title:AIDS Research and Human Retroviruses
language:en
Short-container-title:AIDS Research and Human Retroviruses

Author:

Klasse Per Johan¹,Sanders Rogier W.¹²,Cerutti Andrea³⁴,Moore John P.¹

Affiliation:

1. Department of Microbiology and Immunology, Cornell University, Weill Cornell Medical College, New York, New York.

2. Laboratory of Experimental Virology, Department of Medical Microbiology, Center for Infection and Immunity Amsterdam, Academic Medical Center of the University of Amsterdam, Amsterdam, The Netherlands.

3. Immunology Institute, Department of Medicine, Mount Sinai School of Medicine, New York, New York.

4. Catalan Institute for Research and Advanced Studies, Barcelona Biomedical Research Park, IMIM-Hospital del Mar, Barcelona, Spain.

Publisher

Mary Ann Liebert Inc

Subject

Infectious Diseases,Virology,Immunology

Link

http://www.liebertpub.com/doi/pdf/10.1089/aid.2011.0053

Reference157 articles.

1. Occupancy and mechanism in antibody-mediated neutralization of animal viruses

2. GP120: Target for Neutralizing HIV-1 Antibodies

3. Effective, low-titer antibody protection against low-dose repeated mucosal SHIV challenge in macaques

4. Protection of Macaques against Pathogenic Simian/Human Immunodeficiency Virus 89.6PD by Passive Transfer of Neutralizing Antibodies

5. Antibody Protects Macaques against Vaginal Challenge with a Pathogenic R5 Simian/Human Immunodeficiency Virus at Serum Levels Giving Complete Neutralization In Vitro

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. mRNA-based HIV-1 vaccines;Clinical Microbiology Reviews;2024-09-12

2. The Role of Antibodies in the Treatment of SARS-CoV-2 Virus Infection, and Evaluating Their Contribution to Antibody-Dependent Enhancement of Infection;International Journal of Molecular Sciences;2022-05-28

3. Persistent immunogenicity of integrase defective lentiviral vectors delivering membrane-tethered native-like HIV-1 envelope trimers;npj Vaccines;2022-04-21

4. Antibody profiling reveals gender differences in response to SARS-COVID-2 infection;AIMS Allergy and Immunology;2022

5. Persistent Immunogenicity of Integrase Defective Lentiviral Vectors delivering membrane tethered Native-Like HIV-1 Envelope Trimers;2021-10-09